Salt Lake Potash, Shield Therapeutics and Galliford Try
Justin Waite
Vox Markets Podcast with Justin Waite
13:03, 16th September 2020

AudioBoom Player

DYOR Disclaimer

If you find this podcast useful please give it a rating and review on iTunes by clicking here

Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app


On today's Vox Markets Podcast: Salt Lake Potash, Shield Therapeutics and Galliford Try

Salt Lake Potash Logo

Tony Swiericzuk CEO of Salt Lake Potash #SO4 FOLLOW talks about their Lake Way Project reaching 60% completion.

Salt Lake Potash plans to build the most sustainable, most rewarding fertiliser project in the world by developing organic Sulphate of Potash (SOP) from the Goldfields Salt Lakes which are nine lakes totalling over 3,300km² of playa surface ideal for trench extractions in Western Australia.


Shield Therapeutics logo

Tim Watts, CEO of Shield Therapeutics #STX FOLLOW discusses their Interim Results to 30th June.

Shield is a de-risked, specialty pharmaceutical company focused on commercialising its lead product, Feraccru®/Accrufer®, a novel, stable, non-salt based oral therapy for adults with iron deficiency with or without anaemia. Feraccru®/Accrufer® has been approved for use in the United States, European Union, UK and Switzerland and has exclusive IP rights until the mid-2030s. Feraccru® is commercialised in the UK and Europe by Norgine B.V. and the Company is currently in the process of selecting a commercialisation partner for the US market. Shield also has an exclusive licence agreement with Beijing Aosaikang Pharmaceutical Co., Ltd., for the development and commercialisation of Feraccru®/Accrufer® in China, Hong Kong, Macau and Taiwan.

(Interview starts at 13 minutes 1 seconds)


GALLIFORD TRY logo

Andrew Duxbury, Finance Director of Galliford Try #GFRD FOLLOW talks about their final results and strategy going forward.

Galliford Try is a trading name of Galliford Try Holdings plc, a leading UK construction group listed on the London Stock Exchange. Operating as Galliford Try and Morrison Construction, the group carries out building and infrastructure projects with clients in the public, private and regulated sectors across the UK.

(Interview starts at 24 minutes 8 seconds)  

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Comments
info
Login or register to post comments

Recent Articles
Watchlist